Detalles de la búsqueda
1.
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Med J Aust
; 217(4): 195-202, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781813
2.
SmartStartAllergy: a novel tool for monitoring food allergen introduction in infants.
Med J Aust
; 212(6): 271-275, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31981429
3.
Symptom profile of patients receiving antibiotics for upper respiratory tract infections in general practice: an observational study using smartphone technology.
Fam Pract
; 36(5): 560-567, 2019 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649332
4.
Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.
Euro Surveill
; 20(43)2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536867
5.
Using automated text messages to monitor adverse events following immunisation in general practice.
Med J Aust
; 200(7): 416-8, 2014 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24794676
6.
Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia.
Vaccine
; 42(13): 3166-3171, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38677792
7.
The AuTOMATIC trial: a study protocol for a multi-arm Bayesian adaptive randomised controlled trial of text messaging to improve childhood immunisation coverage.
Trials
; 24(1): 97, 2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750833
8.
Making a SmartStart for peanut introduction to support food allergy prevention guidelines for infants.
J Allergy Clin Immunol Glob
; 2(3): 100102, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779522
9.
Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia.
Hum Vaccin Immunother
; 18(1): 2020573, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254947
10.
Adverse events following influenza immunization: understanding the role of age and sex interactions.
Expert Rev Vaccines
; 21(3): 415-422, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937488
11.
Safety of Four COVID-19 Vaccines across Primary Doses 1, 2, 3 and Booster: A Prospective Cohort Study of Australian Community Pharmacy Vaccinations.
Vaccines (Basel)
; 10(12)2022 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560426
12.
Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children.
J Pediatric Infect Dis Soc
; 10(2): 192-195, 2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333678
13.
Active vaccine safety surveillance of seasonal influenza vaccination via a scalable, integrated system in Western Australian pharmacies: a prospective cohort study.
BMJ Open
; 11(6): e048109, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103321
14.
Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: an observational study using active surveillance.
BMJ Open
; 11(3): e043880, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33766842
15.
Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study.
Swiss Med Wkly
; 151: w30090, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34908642
16.
Immunisation provider experiences with an automated short message service-based active surveillance system for monitoring adverse events following immunisation: A qualitative descriptive study.
Digit Health
; 7: 20552076211038165, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616563
17.
Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
Vaccine
; 38(31): 4892-4900, 2020 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499067
18.
Vaccination reaction rate is unaltered by ambient temperature on the day.
Heliyon
; 6(11): e05527, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33294676
19.
Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
Hum Vaccin Immunother
; 16(12): 3081-3089, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32420793
20.
Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
JAMA Netw Open
; 3(5): e204079, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369177